日本語フィールド
著者：Atsushi Tanaka, Koichi Node題名：Fluid volume regulation in patients with heart failure 発表情報：Lancet Diabetes Endocrinol 巻: 9 号: 5 ページ: 256-257キーワード：概要：AT reports a grant from GlaxoSmithKline and personal fees from Boehringer Ingelheim. KN reports grants from Asahi Kasei, Astellas, Boehringer Ingelheim Japan, Mitsubishi Tanabe Pharma, Teijin Pharma, and Terumo; other funding (scholarships) from Astellas, Bayer Yakuhin, Bristol Myers Squibb, Daiichi Sankyo, Daiichi Sankyo Healthcare, Takeda Pharmaceutical, and Teijin Pharma; and personal fees from Astellas, AstraZeneca, Bayer Yakuhin, Boehringer Ingelheim Japan, Daiichi Sankyo Healthcare, Eli Lilly Japan, Kowa, Mitsubishi Tanabe Pharma, Merck Sharp & Dohme, Novartis, Ono Pharmaceutical, Takeda Pharmaceutical, and Teijin Pharma.抄録：英語フィールド
Author：Atsushi Tanaka, Koichi NodeTitle：Fluid volume regulation in patients with heart failure Announcement information:Lancet Diabetes Endocrinol Vol: 9 Issue: 5 Page: 256-257An abstract：AT reports a grant from GlaxoSmithKline and personal fees from Boehringer Ingelheim. KN reports grants from Asahi Kasei, Astellas, Boehringer Ingelheim Japan, Mitsubishi Tanabe Pharma, Teijin Pharma, and Terumo; other funding (scholarships) from Astellas, Bayer Yakuhin, Bristol Myers Squibb, Daiichi Sankyo, Daiichi Sankyo Healthcare, Takeda Pharmaceutical, and Teijin Pharma; and personal fees from Astellas, AstraZeneca, Bayer Yakuhin, Boehringer Ingelheim Japan, Daiichi Sankyo Healthcare, Eli Lilly Japan, Kowa, Mitsubishi Tanabe Pharma, Merck Sharp & Dohme, Novartis, Ono Pharmaceutical, Takeda Pharmaceutical, and Teijin Pharma.